Skip to main content

Table 3 Endpoints for the trial

From: A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol

Primary endpoint
 The disability-free survival
Secondary endpoint
 1) Lean body mass assessed by CT
 2) Physical function assessed by the hand-grip strength, SPPB score and physical activity measured by accelerometer
 3) Nutritional status assessed by body weight, MNA score and ingested nutritional quantity
 4) Quality of Life assessed by EORTC-QLQ-C30
 5) The proportion of patients treated with subsequent chemotherapy
 6) Overall survival, Progression free survival
 7) The cumulative number of days of hospitalization
 8) Activity of daily life
 9) Safety
  1. CT computed tomography, SPPB short physical performance battery, MNA Mini Nutritional Assessment, EORTC-QLQ The European Organization for Research and Treatment of Cancer Quality-of Life Questionnaire